PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
+41.22%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$172M
AUM Growth
+$51.2M
(+42%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
11.29%
Top 10 Holdings %
Top 10 Hldgs %
82.87%
Holding
37
New
3
Increased
5
Reduced
1
Closed
9
Top Buys
| 1 |
Simplify Enhanced Income ETF
HIGH
|
$25.7M |
| 2 |
Achieve Life Sciences
ACHV
|
$11.1M |
| 3 |
Akero Therapeutics
AKRO
|
$5.75M |
| 4 |
Applied Therapeutics
APLT
|
$5.01M |
| 5 |
Phathom Pharmaceuticals
PHAT
|
$4.53M |
Top Sells
| 1 |
Plains GP Holdings
PAGP
|
$21.9M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$5.87M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
$2.13M |
| 4 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$2.13M |
| 5 |
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
$1.36M |
Sector Composition
| 1 | Healthcare | 78.83% |
| 2 | Technology | 1.46% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBN
26
Cybin
CYBN
$142M
| $351K | 0.2% |
22,368
| – | – |
|
27
Agios Pharmaceuticals
AGIO
$2.36B
| – | – |
-5,792
| Closed | -$129K |
|
|
28
Vanguard Short-Term Bond ETF
BSV
$38.3B
| – | – |
-27,712
| Closed | -$2.13M |
|
|
29
Crinetics Pharmaceuticals
CRNX
$3.26B
| – | – |
-165,000
| Closed | -$5.87M |
|
30
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.78B
| – | – |
-9,267
| Closed | -$283K |
|
31
Heron Therapeutics
HRTX
$204M
| – | – |
-104,195
| Closed | -$177K |
|
|
32
Plains GP Holdings
PAGP
$3.71B
| – | – |
-1,372,360
| Closed | -$21.9M |
|
33
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.36B
| – | – |
-12,148
| Closed | -$598K |
|
|
34
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.39B
| – | – |
-45,695
| Closed | -$1.36M |
|
|
IBDP
35
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| – | – |
-85,442
| Closed | -$2.13M |
|